A surgical polypragmasy: Koninckx PR, Corona R, Timmerman D, Verguts J, Adamyan L. Peritoneal full-conditioning reduces postoperative adhesions and pain: a randomised controlled trial in deep endometriosis surgery. J Ovarian Res. 2013 Dec 11;6(1):90
© Mynbaev et al.; licensee BioMed Central Ltd. 2014
Received: 17 January 2014
Accepted: 4 March 2014
Published: 10 March 2014
In clinical trials most adhesion prevention methods fail. Therefore we have read the article by Koninckx et al.  with great interest. They aim “… to perform a translational proof of concept trial to investigate the effect of full-conditioning (FC) in the human upon CO2 resorption during surgery, …”.
Congratulations to the authors are in order for their valuable clinical results which have demonstrated the efficiency of their attempts to prevent postsurgical adhesions, reducing pain and modulated posttraumatic inflammation with lower postoperative C-reactive protein (CRP) values and accelerated recovery. Since huge obstacles in the setup of clinical studies are met when second-look laparoscopy (SLL) is required, most studies evaluate the efficiency of adhesion prevention adjuvants on the basis of experiments only. It is indeed difficult to organize such kind of clinical trials due to both severe ethical and financial issues and patient requirement difficulties. Therefore, clinical trials aimed to evaluate postsurgical adhesion formation by SLL should be based on a well-defined study question, a distinct design and strictly specified patient selection, all of which may lead to evidence-based conclusions, albeit in a limited number of homogenous population.
However, some shortcomings of this study , which might lead to misleading conclusions, and the authors’ disregard of well-known undesirable N2O side effects have coerced us to write this letter.
Professor Koninckx is an outstanding, worldwide authority in this field who performs high-quality surgical treatment of deep endometriosis. Therefore we may safely assume that for deep endometriosis excision in both groups, identical surgical procedures were performed and that presurgical randomization and postsurgical follow-up were also done up to standard.
However, the patients in the FC group experienced surgical polypragmasy, namely: 1) a humidified pneumoperitoneum gas mixture (86% CO2 + 10% N2O + 4% O2) with controlled gas temperature (31°C); 2) peritoneal cooling (up to 30°C) by sprinkling 2–3 ml/min of Ringers lactate with heparin (1000 IU/L) at room temperature; 3) a Hyalobarrier gel (HBG) application, and 4) 5 mg of dexamethasone administered intramuscularly at the end of surgery. The women in the control group however, were operated by standard laparoscopy with humidified CO2 only and these two completely different treatment approaches were compared. Subsequently, according to the authors’ conclusions, successful adhesion prevention treatment was estimated by FC only.
We quote: “This translational research confirms in the human the efficacy of FC in reducing CO2 resorption and adhesions with in addition less postoperative pain, lower postoperative CRP concentrations and an accelerated recovery” .
It is difficult to identify the cause of the beneficial adhesion prevention impact because of the excessive combination of several factors. Indeed, it is difficult to accept the authors’ conclusion that the adhesion prevention effect is related with FC only, since in these patients HBG was also applied and dexamethasone was administered. Therefore, the abstract section does not reflect their results at all and may lead JOR readers astray.
Another limitation of this study lies in the small number of patients and the complexity of the adhesion score. In the compared groups it is difficult to distinguish between size and severity of adhesions separately. Moreover, upon initial surgery, most patients had already had adhesions resulting from previous surgery. It is a well-known fact that the adhesion score analysis after adhesiolysis is different from that of adhesions after first surgery. It is quite clear that all of these factors, combined with the population heterogeneity in these groups which only have a small number of patients, may lead to biased results.
We previously demonstrated that reduced blood gas changes during CO2 pneumoperitoneum are associated with mixed gas insufflation (MGI) since even a small concentration of O2 added to CO2 results in lower end tidal CO2 (PETCO2) values and slight changes in blood gas parameters in comparison with those of pure CO2 insufflation in rabbits [2, 3]. Also, MGI has a significant impact on ventilation parameters . Subsequently, it is obvious that during surgery, patients in the FC group require less increased tidal volume (TV) and lower ventilation frequency than patients in the standard pneumoperitoneum group. However, this conclusion should be drawn based upon a comprehensive analysis of anesthesiological management including full respiratory and blood gas, acid base parameters without combining raw data of PETCO2, TV and frequency of ventilation.
The authors stated that N2O is safer than CO2 due to its high solubility in water and the higher lung exchange capacity . However, according to available literature, the administration of N2O is associated with neuro-apoptotic/neurotoxic [5, 6] genotoxic effects  and changes in cobalamin (Vitamin B12), methionine synthase and Hcys metabolism [5, 6] the latter being an α-amino acid biosynthesized from methionine by catabolism.
Through these signaling pathways an increased concentration of blood N2O [5, 6] is associated with the expansion of air-filled spaces such as bowel, and pneumothorax [10, 11]; a dose-dependent depression of the ventilatory response to hypoxemia ; increased DNA damage ; endothelial dysfunction with elevated procoagulant status  with increased risk of thromboembolism, atherosclerosis and cardiovascular diseases [5, 6, 13, 14] and long term risk of myocardial infarctions .
It can be put forward that multiple blood clots in the lesion sites will be stabilized as long-term fibrinogenic adhesions transforming later to fibrotic adhesions (Figure 1C) due to changes of the vascular endothelium surface from an anti- to a procoagulant status, the reactivation of blood platelets involving several intrinsic and extrinsic targets in coagulation and fibrinolysis, resulting in alterations of blood clot/fibrin clot structure, and its increased resistance to fibrinolysis .
Surprisingly, several risk factors are related with reproductive functioning, such as: a reduced fertility ; an elevated risk of spontaneous abortion ; in rats, changes in the luteinizing hormone releasing hormone ; N2O-induced teratogenicity , are claimed to be a result of N2O administration.
These N2O effects, combined with other factors due to polypragmasy with multiple compounds of surgical procedures, may lead to unexpected and undesirable side effects when, in various circumstances, its action pathways remain unclear.
Although the clinical relevance of the unfavorable side effects of N2O remains undetermined [12, 20] we should be prudent in introducing N2O as a safe additive compound for the pneumoperitoneum. Moreover, if we take into account the metabolic, procoagulant and DNA damaging properties of N2O it is clear that a spectrum of beneficial and undesirable effects of N2O being insufflated intraperitoneally under pressure have not yet been fully appreciated.
We suggest that the influence of N2O as an additional component gas for the pneumoperitoneum should be investigated in different animal models evaluating a wide range of physiological parameters including blood gases, acid base balance, oxygen/oximetry and metabolite values and this in well-designed experimental studies. Special attention should be given to local intraperitoneal changes such as oxidative stress parameters, the response of peritoneal macrophages and the role of immune reaction pathways. These studies are needed to demonstrate the impact of both, CO2 and N2O on postsurgical adhesions and the homeostasis. This combination might indeed reduce or even solve the adhesion problem, but as long as experimental studies by other research groups do not prove the benefits nor examine the calculated risks, we should continue to use CO2, which is a well-established gas with known pathophysiological mechanisms.
At NESA, we believe in, and are initiating evidence-based studies toward the standardization of surgical procedures in order to avoid the implementation of superfluous technologies instead of relying on surgical excellence. The concept of simple surgical procedures performed with a limited number of instruments and surgical equipment was suggested in cases where an adhesion prevention strategy should be implemented by a personalized approach taking into account individual genetic and constitutional predispositions. Any surgical tool, procedure or combination of gases should be introduced only after it has been proved to add value to existing ones; therefore we should continue to examine the effect of gas mixtures as potential agents leading to adhesion free endoscopy.
In conclusion, this FC clinical trial definitely is a step forward in the surgical treatment of severe deep endometriosis. Future studies with simplified MGI may cast further light on the mechanism of this strategy’s adhesion prevention impact since pure CO2 during laparoscopic surgery produces severe acidosis, blood gas and acid base changes with increased intraperitoneal insufflation pressure.
Second look laparoscopy
Mixed gas insufflation
Journal of ovarian research
New European Surgical Academy
The use of multiple therapeutic modalities to manage a single condition. (#Segen’s Medical Dictionary. © 2012 Farlex, Inc. All rights reserved).
- Koninckx PR, Corona R, Timmerman D, Verguts J, Adamyan L: Peritoneal full-conditioning reduces postoperative adhesions and pain: a randomised controlled trial in deep endometriosis surgery. J Ovarian Res 2013,6(1):90. 10.1186/1757-2215-6-90PubMed CentralView ArticlePubMedGoogle Scholar
- Mynbaev OA, Adamyan LV, Mailova K, Vanacker B, Koninckx PR: Effects of adding small amounts of oxygen to a carbon dioxide-pneumoperitoneum of increasing pressure in rabbit ventilation models. Fertil Steril 2009,92(2):778–784. 10.1016/j.fertnstert.2008.07.019View ArticlePubMedGoogle Scholar
- Mynbaev OA, Molinas CR, Adamyan LV, Vanacker B, Koninckx PR: Reduction of CO(2)-pneumoperitoneum-induced metabolic hypoxaemia by the addition of small amounts of O(2) to the CO(2) in a rabbit ventilated model. A preliminary study. Hum Reprod 2002,17(6):1623–1629. 10.1093/humrep/17.6.1623View ArticlePubMedGoogle Scholar
- Mynbaev OA, Molinas CR, Adamyan LV, Vanacker B, Koninckx PR: Pathogenesis of CO(2) pneumoperitoneum-induced metabolic hypoxemia in a rabbit model. J Am Assoc Gynecol Laparosc 2002,9(3):306–314. 10.1016/S1074-3804(05)60409-4View ArticlePubMedGoogle Scholar
- Badner N, Drader K, Freeman D, Spence JD: The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesth Analg 1998, 87: 711–713.PubMedGoogle Scholar
- Baum VC: When nitrous oxide is no laughing matter: nitrous oxide and pediatric anesthesia. Paediatr Anaesth 2007,17(9):824–830. 10.1111/j.1460-9592.2007.02264.xView ArticlePubMedGoogle Scholar
- Diamond MP, El-Hammady E, Wang R, Saed G: Metabolic regulation of collagen I in fibroblasts isolated from normal peritoneum and adhesions by dichloroacetic acid. Am J Obstet Gynecol 2002,187(6):1456–1460. 10.1067/mob.2002.129159View ArticlePubMedGoogle Scholar
- Wrońska-Nofer T, Nofer JR, Jajte J, Dziubałtowska E, Szymczak W, Krajewski W, Wąsowicz W, Rydzyński K: Oxidative DNA damage and oxidative stress in subjects occupationally exposed to nitrous oxide (N(2)O). Mutat Res 2012,731(1–2):58–63.View ArticlePubMedGoogle Scholar
- Zhen Y, Dong Y, Wu X, Xu Z, Lu Y, Zhang Y, Norton D, Tian M, Li S, Xie Z: Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology 2009,111(4):741–752. 10.1097/ALN.0b013e3181b27fd4PubMed CentralView ArticlePubMedGoogle Scholar
- Munson ES: Transfer of nitrous oxide into body air cavities. Br J Anaesth 1974,46(3):202–209. 10.1093/bja/46.3.202View ArticlePubMedGoogle Scholar
- Kaur S, Cortiella J, Vacanti CA: Diffusion of nitrous oxide into the pleural cavity. Br J Anaesth 2001,87(6):894–896. 10.1093/bja/87.6.894View ArticlePubMedGoogle Scholar
- Tobias JD: Applications of nitrous oxide for procedural sedation in the pediatric population. Pediatr Emerg Care 2013,29(2):245–265. 10.1097/PEC.0b013e318280d824View ArticlePubMedGoogle Scholar
- Karolczak K, Olas B: Mechanism of action of homocysteine and its thiolactone in hemostasis system. Physiol Res 2009,58(5):623–633.PubMedGoogle Scholar
- Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: a risk factor for vascular disease. N Engl J Med 1991, 324: 1149–1155. 10.1056/NEJM199104253241701View ArticlePubMedGoogle Scholar
- Leslie K, Myles PS, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, Williamson E: Nitrous oxide and longterm morbidity and mortality in the ENIGMA trial. Anesth Analg 2011,112(2):387–393. 10.1213/ANE.0b013e3181f7e2c4View ArticlePubMedGoogle Scholar
- Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ: Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Engl J Med 1992,327(14):993–997. 10.1056/NEJM199210013271405View ArticlePubMedGoogle Scholar
- Rowland AS, Baird DD, Shore DL, Weinberg CR, Savitz DA, Wilcox AJ: Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol 1995,141(6):531–538.PubMedGoogle Scholar
- Kugel G, Letelier C, Zive MA, King JC: Nitrous oxide and infertility. Anesth Prog 1990,37(4):176–180.PubMed CentralPubMedGoogle Scholar
- Fujinaga M, Baden JM: Methionine prevents nitrous oxide-induced teratogenicity in rat embryos grown in culture. Anesthesiology 1994,81(1):184–189. 10.1097/00000542-199407000-00025View ArticlePubMedGoogle Scholar
- Myles PS: Nitrous oxide: deep in the zone of uncertainty. Anesthesiology 2013,119(1):1–3. 10.1097/ALN.0b013e3182976204View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.